VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LULufax Holding Ltd
$9.34$809M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLUBalance Sheet

Lufax Holding Ltd (LU) Balance Sheet

9Y historyFree accessUpdated daily

Equity-to-assets near 0.39 alongside a shrinking base of total assets ($207.5B in 2026Q3) and ROE of -1.8% suggests capital is eroding under credit losses, with cash and bank balances falling to $37.1B from $51.4B in 2024Q2.

Income StatementBalance SheetCash FlowRatios

LU Balance Sheet

Annual statement

LU Balance Sheet

Lufax Holding Ltd (LU) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Cash & Short Term Investments152.06B31.2B33.23B44.37B50.62B79.75B55.95B36.26B30.23B30.34B
Cash & Due from Banks37.11B24.85B32.13B44.37B50.62B79.75B55.95B36.26B30.06B30.23B
Short Term Investments06.36B1.1B00000170.72M102.04M
Total Investments148.55B157.94B141.93B171.62B279.32B312.87B192.08B84.05B62.14B135.55B
Investments Growth %613.74%11.28%-17.3%-38.56%-10.72%62.89%128.53%35.26%-54.16%-
Long-Term Investments466.11B151.59B140.83B171.62B279.32B312.87B192.08B84.05B61.97B135.45B
Accounts Receivables109.81B3.79B4.92B4.49B9.11B00000
Goodwill & Intangibles10.05B11.21B10.78B10.83B11.16B12.01B12.96B12.24B12.64B12.77B
Goodwill9.15B10.2B9.76B9.86B10.15B00000
Intangible Assets903.74M1.01B1.02B968.36M1.01B12.01B12.96B12.24B12.64B12.77B
PP&E (Net)255.03M355.62M394.32M670.5M1.25B1.45B1.66B1.6B1.55B1.87B
Other Assets768.18M3.86B3.56B5.17B10.27B11.27B11.5B12.21B9.23B4.42B
Total Current Assets40.31B56.75B53.76B64.78B92.02B97.34B72.91B53.81B45.47B58.07B
Total Non-Current Assets167.23B174.78B162.77B194.64B307.7B343.56B222.18B113.46B89B158.44B
Total Assets207.55B231.53B216.52B259.41B399.72B440.91B295.09B167.27B134.47B216.51B
Asset Growth %19.69%6.93%-16.53%-35.1%-9.34%49.41%76.42%24.39%-37.89%-
Return on Assets (ROA)-1.43%-1.02%-1.75%0.27%2.17%5.5%6%10.02%9.19%3.18%
Accounts Payable6.74B139.13M51.14M125.43M221.77M00000
Total Debt93.23B80.06B62.1B51.12B64.31B54.8B34.32B33.76B34.2B35.75B
Net Debt56.12B55.21B29.97B6.75B13.7B-24.95B-21.63B-2.5B4.14B5.52B
Long-Term Debt79.16B77.92B60.94B49.22B59.64B22.11B29.86B29.25B27.29B16.47B
Short-Term Debt13.86B1.85B832.38M1.45B3.81B32.28B3.98B4B6.51B18.82B
Other Liabilities27.14B6.57B4.71B4.85B6.75B268.06B155.39B80.13B60.93B159.28B
Total Current Liabilities13.86B54.64B60.58B99.56B221.66B32.28B3.98B4B6.51B18.82B
Total Non-Current Liabilities113.71B85.61B67.01B57.49B71.37B292.95B192.53B116.1B94.91B179.1B
Total Liabilities127.57B140.26B127.59B157.04B293.03B325.23B196.51B120.1B101.42B197.91B
Total Equity79.97B91.27B88.93B102.37B106.69B115.67B98.59B47.17B33.05B18.6B
Equity Growth %1.38%2.63%-13.13%-4.05%-7.76%17.33%109%42.71%77.74%-
Equity / Assets (Capital Ratio)38.53%39.42%41.07%39.46%26.69%26.23%33.41%28.2%24.58%8.59%
Return on Equity (ROE)-3.6%-2.55%-4.35%0.84%8.19%18.91%19.05%37.69%62.47%36.99%
Book Value per Share18455.201053.101274.861786.331859.261701.351751.07765.65536.49301.84
Tangible BV per Share16135.22923.701120.361597.321664.821524.711520.91566.96331.3894.52
Common Stock116.98K130.16K124.46K83.01K85.42K91.74K91.29K77.18K77.54K80.43K
Additional Paid-in Capital27.03B30.07B28.75B35.58B36.53B40.82B39.38B15.79B16.09B13.05B
Retained Earnings54.26B63.08B62.55B69.36B70.45B68.43B48.53B32.83B18.52B3.21B
Accumulated OCI1.88B1.94B1.69B1.96B4.3B11.38B8.8B-1.56B-1.58B1.65B
Treasury Stock-5.64B-6.28B-6B-6.25B-6.43B-6.8B-2.37K-2.24K-1.14K-1.2K
Preferred Stock0000000000

Key Metrics

Growth RegimeContracting
ProfitabilityWeak
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

Credit losses eroding capital base

Shrinking Balance Sheet Under Credit Pressure

According to recent SEC filings, Lufax's total assets fell from $233.1B in 2024Q2 to $207.5B in 2026Q3, while equity declined from $87.1B to $77.5B, signaling a balance sheet contracting under sustained credit losses and negative returns rather than organic expansion.

The decline in total assets alongside falling equity suggests the company is shrinking its risk-bearing book as it absorbs provisions, which may indicate the transition to a balance-sheet lender is proceeding under financial strain. The equity-to-assets ratio has hovered near 0.39 to 0.43, which is not a collapse but leaves limited cushion if losses persist. Investors should monitor whether asset contraction stabilizes or continues, as the current trend warrants further investigation.

Provisions Consuming Loan Book Earnings

As reported in financial statements, loan loss charges reached $4.8B in 2026Q2 and $4.6B in 2025Q4, against net interest income of $3.9B in the same periods, suggesting credit costs are consuming more than the entire spread earned on the loan book.

Provision levels that exceed net interest income point to asset quality deterioration in the small business loan book rather than a temporary timing mismatch. The sustained cost of credit appears tied to the SBO segment weakness flagged in prior analysis. Investors should monitor whether provisioning peaks, as the absence of disclosed coverage ratios limits confidence in whether reserves are adequate.

Equity Base Eroding Through Losses

Based on Lufax's reported figures, equity fell from $91.3B in 2026Q2 to $77.5B in 2026Q3 as the quarter posted a $1.5B net loss in 2025Q3 and ROE remained negative across most periods, indicating capital is being depleted by operating losses.

With ROE negative across recent quarters, capital generation from earnings appears absent, and the reduction in equity suggests losses and shareholder distributions are outpacing any retained buffer. Regulatory capital ratios such as CET1 are not provided in the supplied data, so the true capital buffer cannot be confirmed. This gap warrants further investigation before assessing solvency headroom.

Cash Position Thins Against Obligations

According to reported balance sheet data, cash and bank balances declined from $51.4B in 2024Q2 to $37.1B in 2026Q3, with the 2026Q1 reading falling to $19.2B, suggesting liquidity buffers have been drawn down during the credit cycle.

The decline in cash alongside sustained operating cash flow weakness implies the liquidity cushion is being used to absorb losses and fund shareholder returns. Reliance on core deposits versus wholesale funding cannot be assessed from the supplied data, so the funding mix remains unclear. Investors should monitor whether cash stabilizes, as further declines may increase reliance on external funding.

Recovery Signal May Prove Temporary

As reported in financial statements, the 2026Q3 rebound to $3.9B net interest income and a 1.9% NIM may not be durable, since prior quarters showed similar spikes reversing into losses, including a $1.5B net loss in 2025Q3.

Quarterly NII has oscillated sharply between negative and strong readings, which suggests the latest improvement may reflect timing effects rather than a structural shift in spread economics. Without consistent positive earnings, the rebound does not yet confirm a return to capital generation. Investors should treat the recovery as unconfirmed until several consecutive quarters validate it.

LU — Frequently Asked Questions

Quick answers to the most common questions about buying LU stock.

What are the total assets of Lufax Holding Ltd (LU)?

As of 2025, Lufax Holding Ltd (LU) had total assets of $231.53B including $56.75B in current assets.

How much debt does Lufax Holding Ltd (LU) have?

Lufax Holding Ltd (LU) carries total debt of $80.06B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Lufax Holding Ltd?

Lufax Holding Ltd (LU) has total shareholders' equity (book value) of $88.81B ($1053.10 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Lufax Holding Ltd's current ratio and liquidity?

Lufax Holding Ltd (LU) reported a current ratio of 1.04x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.